✦ LIBER ✦

786 The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

✍ Scribed by Brandse, Johannan F.; van der Kleij, Desiree; Wolbink, Gert-Jan; Rigter, Irma M.; Baars, Paul A.; Lowenberg, M.; Ponsioen, Cyriel; Jansen, Jeroen M.; van den Brink, Gijs R.; Mathôt, Ron A.; D'Haens, Geert R.

Book ID: 122254649
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 135 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60474-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P476 Induction therapy with infliximab i

P476 Induction therapy with infliximab in children with moderate to severe ulcerative colitis

✍ Szychta, M.; Dadalski, M.; Landowski, P.; Klincewicz, B.; Sladek, M.; Karolewska 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 57 KB

Sa1204 Pharmacokinetics of Adalimumab in

Sa1204 Pharmacokinetics of Adalimumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

✍ Awni, Walid M.; Eckert, Doerthe; Sharma, Shringi; Mostafa, Nael M.; Noertersheus 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 170 KB

P412 Pharmacokinetics of adalimumab in a

P412 Pharmacokinetics of adalimumab in adult patients with moderately to severely active ulcerative colitis

✍ Awni, W.; Eckert, D.; Sharma, S.; Mostafa, N.; Noertersheuser, P.; Pradhan, R.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 56 KB

Outcomes after escalation of infliximab

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

✍ E. Rostholder; A. Ahmed; A. S. Cheifetz; A. C Moss 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

212 Serum CRP Is a Better Early Marker f

212 Serum CRP Is a Better Early Marker for Response to Infliximab Induction Therapy Than Fecal Calprotectin in Patients With Moderate to Severe Ulcerative Colitis

✍ Brandse, Johannan F.; Jansen, Jeroen M.; Baars, Paul A.; Lowenberg, M.; Ponsioen 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 496 KB

P350 Serum CRP is a better early marker

P350 Serum CRP is a better early marker for response to infliximab induction therapy than fecal calprotectin in patients with moderate to severe ulcerative colitis

✍ Brandse, J.F.; Jansen, J.M.; Baars, P.A.; Löwenberg, M.; Ponsioen, C.Y.; van den 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 268 KB